Literature DB >> 6126152

Neurotransmitter chemistry in feline GM1 gangliosidosis: a model for human ganglioside storage disease.

H S Singer, J T Coyle, D L Weaver, N Kawamura, H J Baker.   

Abstract

Assays for synaptosomal high-affinity uptake activity (glutamate, gamma-aminobutyric acid, norepinephrine), neurotransmitter synthesizing enzymes (choline acetyltransferase, glutamate decarboxylase, tyrosine hydroxylase), and endogenous neurotransmitters were performed in cats with advanced inherited GM1 gangliosidosis. A significant reduction in uptake activity, ranging from 24 to 77% of control, was demonstrated in motor, occipital, and cerebellar brain regions. This reduction was unassociated with comparable alterations in neurotransmitter levels or synthesizing enzyme activity. We hypothesize that the defect of neurotransmitter inactivation is part of an overall abnormality of synaptic membrane function that could contribute to the neurological symptoms seen in the hereditary gangliosidoses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126152     DOI: 10.1002/ana.410120107

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

1.  Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts from controls, metachromatic leukodystrophy, and globoid cell leukodystrophy.

Authors:  K Inui; M Furukawa; S Okada; H Yabuuchi
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease.

Authors:  M Taniike; S Yamanaka; R L Proia; C Langaman; T Bone-Turrentine; K Suzuki
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.

Authors:  Douglas R Martin; Brigitte A Rigat; Polly Foureman; G S Varadarajan; Misako Hwang; Barbara K Krum; Bruce F Smith; John W Callahan; Don J Mahuran; Henry J Baker
Journal:  Mol Genet Metab       Date:  2008-03-18       Impact factor: 4.797

4.  GM1 gangliosidosis, type 2: ocular clinicopathologic correlation.

Authors:  L J Cairns; W R Green; H S Singer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.